ADHD Awareness Month: Addressing Disparities in Diagnosis and Treatment
October is ADHD Awareness Month, dedicated to raising awareness about Attention Deficit Hyperactivity Disorder (ADHD) and combating the stigma associated with it. According to the Centers for Disease...
View ArticleClik here to view.
Webinar: New Findings on Inequities in Rare Diseases: How They Impact...
Join us Tuesday, October 29, at noon Eastern for an important webinar, New Findings on Inequities in Rare Diseases: How They Impact Research and Clinical Trials Processes.” This session will be...
View ArticleClik here to view.
Webinar: Advanced in vitro modelling of neuromuscular diseases and therapeutics
Join us on November 14 at 12 p.m. eastern for a webinar that will explore innovative, multidisciplinary approaches in disease modeling, drug testing, and tissue engineering using advanced in vitro...
View ArticleClik here to view.
2025 Clinical Outcome Assessment Program Annual Meeting
Save the Date!2025 Clinical Outcome Assessment Program Annual Meeting On April 9-10, 2025, the 2025 Clinical Outcome Assessment Program Annual Meeting will be held at the Bethesda North Marriott &...
View ArticleThe Path to Accessibility: Installing ADA-Friendly Solutions
When C-Path launched its new website, it was built to be sleek, mobile, responsive and navigable. But there was one more key element: an integration that would install top-end solutions for those...
View ArticleClik here to view.
C-Path Announces Key Leadership Appointments in Neurodegenerative Disease...
Dr. Diane Stephenson Promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as New Executive Director of CPAD TUCSON, Ariz., November 7, 2024 — Critical Path Institute® (C-Path) today...
View ArticleC-Path Announces Gender Equitable Medicines for Parkinson’s Disease (GEM‑PD)...
C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., November 13, 2024 — Critical Path Institute®...
View ArticleClik here to view.
C-Path’s Initiative to Optimize Clinical Trial Design in New-Onset Type 1...
In honor of World Diabetes Day and the need to improve diabetes treatment, Critical Path Institute’s Type 1 Diabetes Consortium (T1DC) would like to highlight its development of a regulatory grade...
View ArticleClik here to view.
Advancing Neonatal Drug Development: Celebrating Progress on World...
On this occasion of World Prematurity Awareness Day, we reflect on the immense progress we have made together and recognize the vital role you have played in advancing neonatal drug development. At...
View ArticleClik here to view.
C-Path’s TRxA Announces $1 Million Award for Drug Development Project in Type...
TUCSON, Ariz., November 19, 2024 — Critical Path Institute® (C-Path) today announced that its Translational Therapeutics Accelerator (TRxA) program, in partnership with The Leona M. and Harry B....
View Article